Thomas Berger - Publications

Affiliations: 
University of Bern, Bern, Bern, Switzerland 

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lopes RT, Meyer B, Berger T, Svacina MA. Effectiveness of an internet-based self-guided program to treat depression in a sample of Brazilian users: a study protocol. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 32159711 DOI: 10.1590/1516-4446-2019-0582  0.305
2019 Moser C, Bachem R, Berger T, Maercker A. ZIEL: Internet-Based Self-Help for Adjustment Problems: Results of a Randomized Controlled Trial. Journal of Clinical Medicine. 8. PMID 31614528 DOI: 10.3390/jcm8101655  0.301
2019 Klein JP, Berger T, Hautzinger M, Lutz W, Rose M, Späth C, Schröder J, Hohagen F, Moritz S. [Self-management interventions in the treatment of depressive disorders: ready for clinical practice?] Fortschritte Der Neurologie-Psychiatrie. 87: 172-180. PMID 30891718 DOI: 10.1055/A-0849-9838  0.308
2019 AlTahan AM, Berger T, AlOrainy IA, AlTahan H. Progressive Multifocal Leukoencephalopathy in the Absence of Typical Radiological Changes: Can We Make a Diagnosis? The American Journal of Case Reports. 20: 101-105. PMID 30674865 DOI: 10.12659/AJCR.911521  0.304
2018 Di Pauli F, Berger T. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders? Frontiers in Immunology. 9: 2753. PMID 30555462 DOI: 10.3389/fimmu.2018.02753  0.307
2018 Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, et al. International consensus on quality standards for brain health-focused care in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518809326. PMID 30381987 DOI: 10.1177/1352458518809326  0.3
2018 Klein JP, Hauer A, Berger T, Fassbinder E, Schweiger U, Jacob G. Protocol for the REVISIT-BPD Trial, a Randomized Controlled Trial Testing the Effectiveness of an Internet-Based Self-Management Intervention in the Treatment of Borderline Personality Disorder (BPD). Frontiers in Psychiatry. 9: 439. PMID 30298024 DOI: 10.3389/fpsyt.2018.00439  0.303
2018 Weisel KK, Zarski AC, Berger T, Schaub MP, Krieger T, Moser CT, Berking M, Ebert DD. Transdiagnostic Tailored Internet- and Mobile-Based Guided Treatment for Major Depressive Disorder and Comorbid Anxiety: Study Protocol of a Randomized Controlled Trial. Frontiers in Psychiatry. 9: 274. PMID 30022954 DOI: 10.3389/fpsyt.2018.00274  0.308
2018 Karyotaki E, Ebert DD, Donkin L, Riper H, Twisk J, Burger S, Rozental A, Lange A, Williams AD, Zarski AC, Geraedts A, van Straten A, Kleiboer A, Meyer B, Ünlü Ince BB, ... Berger T, et al. Do guided internet-based interventions result in clinically relevant changes for patients with depression? An individual participant data meta-analysis. Clinical Psychology Review. 63: 80-92. PMID 29940401 DOI: 10.1016/J.Cpr.2018.06.007  0.31
2018 Hegen H, Bsteh G, Berger T. "No evidence of disease activity" - is it an appropriate surrogate in multiple sclerosis? European Journal of Neurology. PMID 29687559 DOI: 10.1111/ene.13669  0.309
2017 Berger T. Biomarkers in the evolution of multiple sclerosis. Neurodegenerative Disease Management. 7: 3-6. PMID 29143589 DOI: 10.2217/nmt-2017-0033  0.305
2017 Peschl P, Bradl M, Höftberger R, Berger T, Reindl M. Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases. Frontiers in Immunology. 8: 529. PMID 28533781 DOI: 10.3389/fimmu.2017.00529  0.304
2016 Schulz A, Stolz T, Vincent A, Krieger T, Andersson G, Berger T. A sorrow shared is a sorrow halved? A three-arm randomized controlled trial comparing internet-based clinician-guided individual versus group treatment for social anxiety disorder. Behaviour Research and Therapy. 84: 14-26. PMID 27423374 DOI: 10.1016/j.brat.2016.07.001  0.303
2015 Ehling R, Di Pauli F, Lackner P, Rainer C, Kraus V, Hegen H, Lutterotti A, Kuenz B, De Zordo T, Schocke M, Glatzl S, Löscher WN, Deisenhammer F, Reindl M, Berger T. Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial. Journal of Neuroimmunology. 287: 98-105. PMID 26439969 DOI: 10.1016/j.jneuroim.2015.08.004  0.315
2015 Ramberger M, Bsteh G, Schanda K, Höftberger R, Rostásy K, Baumann M, Aboulenein-Djamshidian F, Lutterotti A, Deisenhammer F, Berger T, Reindl M. NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases. Neurology® Neuroimmunology & Neuroinflammation. 2: e141. PMID 26309901 DOI: 10.1212/NXI.0000000000000141  0.309
2015 Berger T, Reindl M. Antibody biomarkers in CNS demyelinating diseases - a long and winding road. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 1162-8. PMID 26010364 DOI: 10.1111/ene.12759  0.305
2015 Meyer B, Bierbrodt J, Schröder J, Berger T, Beevers CG, Weiss M, Jacob G, Späth C, Andersson G, Lutz W, Hautzinger M, Löwe B, Rose M, Hohagen F, Caspar F, et al. Effects of an Internet intervention (Deprexis) on severe depression symptoms: Randomized controlled trial Internet Interventions. 2: 48-59. DOI: 10.1016/J.Invent.2014.12.003  0.304
2013 Klein JP, Berger T, Schröder J, Späth C, Meyer B, Caspar F, Lutz W, Greiner W, Hautzinger M, Rose M, Gräfe V, Hohagen F, Andersson G, Vettorazzi E, Moritz S. The EVIDENT-trial: protocol and rationale of a multicenter randomized controlled trial testing the effectiveness of an online-based psychological intervention. Bmc Psychiatry. 13: 239. PMID 24074299 DOI: 10.1186/1471-244X-13-239  0.301
2013 Fazekas F, Bajenaru O, Berger T, Fabjan TH, Ledinek AH, Jakab G, Komoly S, Kobys T, Kraus J, Kur?a E, Kyriakides T, Lisý L, Milanov I, Nehrych T, Moskovko S, et al. How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis? Frontiers in Neurology. 4: 10. PMID 23641231 DOI: 10.3389/fneur.2013.00010  0.318
2011 Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, ... ... Berger T, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. Journal of Neuroinflammation. 8: 184. PMID 22204662 DOI: 10.1186/1742-2094-8-184  0.304
2011 Rahman J, Berger T. Persistent activity in layer 5 pyramidal neurons following cholinergic activation of mouse primary cortices. The European Journal of Neuroscience. 34: 22-30. PMID 21645136 DOI: 10.1111/j.1460-9568.2011.07736.x  0.307
2010 Ehling R, Berger T, Reindl M. Multiple sclerosis - established and novel therapeutic approaches. Central Nervous System Agents in Medicinal Chemistry. 10: 3-15. PMID 20236038 DOI: 10.2174/187152410790780127  0.314
2010 Haemmerli K, Znoj H, Berger T. Internet-based support for infertile patients: a randomized controlled study Journal of Behavioral Medicine. 33: 135-146. PMID 20039196 DOI: 10.1007/S10865-009-9243-2  0.31
2010 Almlöv J, Carlbring P, Berger T, Cuijpers P, Andersson G. Therapist factors in Internet-delivered cognitive behavioural therapy for major depressive disorder. Cognitive Behaviour Therapy. 38: 247-54. PMID 19802751 DOI: 10.1080/16506070903116935  0.302
2009 Berger T. Current therapeutic recommendations in multiple sclerosis. Journal of the Neurological Sciences. 287: S37-45. PMID 20106347 DOI: 10.1016/S0022-510X(09)71299-7  0.315
2009 Benhassine N, Berger T. Large-conductance calcium-dependent potassium channels prevent dendritic excitability in neocortical pyramidal neurons. Pflã¼Gers Archiv : European Journal of Physiology. 457: 1133-45. PMID 18762971 DOI: 10.1007/s00424-008-0569-3  0.758
2008 Markopoulos F, Neubauer FB, Berger T, Scotti AL. Reassembling a system from the sensor to cerebral representation: the olfactory system in vitro. Neuroscience. 156: 1048-63. PMID 18773940 DOI: 10.1016/j.neuroscience.2008.07.071  0.664
2008 Calì C, Berger TK, Pignatelli M, Carleton A, Markram H, Giugliano M. Inferring connection proximity in networks of electrically coupled cells by subthreshold frequency response analysis. Journal of Computational Neuroscience. 24: 330-45. PMID 18044016 DOI: 10.1007/s10827-007-0058-2  0.653
2008 Neubauer FB, Berger T. Somatodendritic integration under increased network activity in layer 5 pyramidal cells of the somatosensory cortex. Pflã¼Gers Archiv : European Journal of Physiology. 455: 1063-79. PMID 17952691 DOI: 10.1007/s00424-007-0350-z  0.705
2007 Kuenz B, Deisenhammer F, Berger T, Reindl M. Diagnostic biomarkers in multiple sclerosis. Expert Opinion On Medical Diagnostics. 1: 225-233. PMID 23489309 DOI: 10.1517/17530059.1.2.225  0.301
2007 Lutterotti A, Berger T, Reindl M. Biological markers for multiple sclerosis. Current Medicinal Chemistry. 14: 1956-1965. PMID 17691938 DOI: 10.2174/092986707781368478  0.305
2007 Berger T, Reindl M. Multiple sclerosis: disease biomarkers as indicated by pathophysiology. Journal of the Neurological Sciences. 259: 21-26. PMID 17367811 DOI: 10.1016/J.Jns.2006.05.070  0.303
2007 Berger T, Borgdorff A, Crochet S, Neubauer FB, Lefort S, Fauvet B, Ferezou I, Carleton A, Lüscher HR, Petersen CC. Combined voltage and calcium epifluorescence imaging in vitro and in vivo reveals subthreshold and suprathreshold dynamics of mouse barrel cortex. Journal of Neurophysiology. 97: 3751-62. PMID 17360827 DOI: 10.1152/Jn.01178.2006  0.687
2006 Reindl M, Khalil M, Berger T. Antibodies as biological markers for pathophysiological processes in MS. Journal of Neuroimmunology. 180: 50-62. PMID 16934337 DOI: 10.1016/J.Jneuroim.2006.06.028  0.303
2006 Berger T, Lüscher HR, Giugliano M. Transient rhythmic network activity in the somatosensory cortex evoked by distributed input in vitro. Neuroscience. 140: 1401-13. PMID 16632207 DOI: 10.1016/j.neuroscience.2006.03.003  0.702
2005 Benhassine N, Berger T. Homogeneous distribution of large-conductance calcium-dependent potassium channels on soma and apical dendrite of rat neocortical layer 5 pyramidal neurons. The European Journal of Neuroscience. 21: 914-26. PMID 15787698 DOI: 10.1111/j.1460-9568.2005.03934.x  0.742
2004 Berger T, Lüscher HR. Associative somatodendritic interaction in layer V pyramidal neurons is not affected by the antiepileptic drug lamotrigine. The European Journal of Neuroscience. 20: 1688-93. PMID 15355337 DOI: 10.1111/j.1460-9568.2004.03617.x  0.302
2003 Berger T, Senn W, Lüscher HR. Hyperpolarization-activated current Ih disconnects somatic and dendritic spike initiation zones in layer V pyramidal neurons. Journal of Neurophysiology. 90: 2428-37. PMID 12801902 DOI: 10.1152/jn.00377.2003  0.31
2001 Berger T, Larkum ME, Lüscher HR. High I(h) channel density in the distal apical dendrite of layer V pyramidal cells increases bidirectional attenuation of EPSPs. Journal of Neurophysiology. 85: 855-68. PMID 11160518 DOI: 10.1152/Jn.2001.85.2.855  0.681
Show low-probability matches.